- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 110.88M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 147.16M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $5.69M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $2.84M |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $782K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $15.05M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $883K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $39.72M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $41.16M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $51.61M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $618.71M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $600.11M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $255.69M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $301.66M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.14B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.18B |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.59M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.3M |
| Net Income | Q1 2026 · Mar 31, 2026 | $7.7M |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.91M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$10.66M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$8.41M |
| Revenue | Q1 2026 · Mar 31, 2026 | $73.11M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $57.09M |